Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL194139 | 0.95 | — | — | |
| Water SCHEMBL10717161 | 0.90 | — | — | |
| Iodide SCHEMBL27951208 | 0.90 | — | — | |
| Bromide SCHEMBL27564189 | 0.90 | — | — | |
| SCHEMBL8024208 | 0.90 | — | — | |
| Thiocyanic Acid SCHEMBL28755250 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL9400701 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL2644310 | 0.70 | — | — | |
| SCHEMBL17664699 | 0.70 | — | — | |
| SCHEMBL21116421 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 767 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118420533-A | Method for synthesizing isoquinolinone by carbonylation of aryl alkyne and hydroxylamine | 中国科学技术大学 | 2024-08-02 | — | — | CN | claimed |
| US-20240189242-A1 | LIPID NANOPARTICLE COMPOSITIONS AND METHODS OF FORMULATING THE SAME | MODERNATX, INC. (US) | 2024-06-13 | — | — | US | claimed |
| CN-110330489-B | Quinolone thiazole oxime compound and preparation method and application thereof | 西南大学 | 2023-11-21 | — | — | CN | claimed |
| US-11723362-B2 | Broad-spectrum synergistic antimicrobial compositions | -The United States of America, as represented by The Secretary of Agriculture (US) | 2023-08-15 | — | — | US | claimed |
| WO-2022178199-A1 | LIPID NANOPARTICLE COMPOSITIONS AND METHODS OF FORMULATING THE SAME | MODERNATX, INC. (US) | 2022-08-25 | — | — | WO | claimed |
| EP-4030915-A1 | BROAD-SPECTRUM SYNERGISTIC ANTIMICROBIAL COMPOSITIONS | The United States of America as represented by the Secretary of Agriculture (US) | 2022-07-27 | — | — | EP | claimed |
| CN-113884484-A | Color-changing material for detecting and removing formaldehyde and preparation method and application thereof | 陕西科技大学 | 2022-01-04 | — | — | CN | claimed |
| US-20210084896-A1 | BROAD-SPECTRUM SYNERGISTIC ANTIMICROBIAL COMPOSITIONS | METHOD PRODUCTS, PBC, | 2021-03-25 | — | — | US | claimed |
| WO-2021055720-A1 | BROAD-SPECTRUM SYNERGISTIC ANTIMICROBIAL COMPOSITIONS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2021-03-25 | — | — | WO | claimed |
| CN-109467625-B | Aniline oxime catalyst and preparation method thereof | 东华大学 | 2020-06-12 | — | — | CN | claimed |
| US-8101758-B2 | Stereoselective process and crystalline forms of a camptothecin | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 2012-01-24 | — | — | US | claimed |
| US-20100311784-A1 | STEREOSELECTIVE PROCESS AND CRYSTALLINE FORMS OF A CAMPTOTHECIN | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITIE SPA (IT) | 2010-12-09 | — | — | US | claimed |
| US-20100311783-A1 | STEREOSELECTIVE PROCESS AND CRYSTALLINE FORMS OF A CAMPTOTHECIN | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITIE SPA (IT) | 2010-12-09 | — | — | US | claimed |
| US-7799921-B2 | Stereoselective process and crystalline forms of a camptothecin | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 2010-09-21 | — | — | US | claimed |
| US-20090239893-A1 | STEREOSELECTIVE PROCESS AND CRYSTALLINE FORMS OF A CAMPTOTHECIN | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 2009-09-24 | — | — | US | claimed |
| EP-1828196-A2 | STEREOSELECTIVE PROCESS AND CRYSTALLINE FORMS OF A CAMPTOTHECIN | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. (IT) | 2007-09-05 | — | — | EP | claimed |
| WO-2006067092-A2 | STEREOSELECTIVE PROCESS AND CRYSTALLINE FORMS OF A CAMPTOTHECIN | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 2006-06-29 | — | — | WO | claimed |
| US-6512143-B1 | Salt formation by reaction of alkanoic acid with N-tert-butylhydroxylamine | ASTRAZENECA AB (CH) | 2003-01-28 | — | — | US | claimed |
| EP-1095012-A1 | NOVEL SALTS OF N-TERT-BUTYLHYDROXYLAMINE | AstraZeneca AB (SE) | 2001-05-02 | — | — | EP | claimed |
| WO-2000002848-A1 | NOVEL SALTS OF N-TERT-BUTYLHYDROXYLAMINE | ASTRAZENECA AB (SE) | 2000-01-20 | — | — | WO | claimed |